Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Application
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
AHU377-d4 is intended for use as an internal standard for the quantification of AHU377 (Item Nos. 36230 | 21473) by GC- or LC-MS. AHU377 is an ethyl ester prodrug form of the neprilysin inhibitor LBQ657 (Item No. 19829).1 It increases plasma levels of atrial natriuretic factor (ANF) in conscious rats and anesthetized dogs when administered at doses of 10 and 30 mg/kg, respectively. AHU377 (30 mg/kg) increases ANF-induced urinary sodium excretion in anesthetized rats. Formulations containing AHU377 in combination with valsartan have been used in the treatment of mild to moderate hypertension and chronic heart failure.
WARNING This product is not for human or veterinary use.
1. Dicarboxylic acid dipeptide neutral endopeptidase inhibitors. J. Med. Chem. 38(10), 1689-1700 (1995).